Analysis of Efficacy of Surgical Treatment for IIIa Small Cell Lung Cancer
Background and objective Small cell lung cancer (SCLC) accounts for nearly 15% of all cases of cancer. As a type of highly invasive tumors, SCLC has high degree of malignancy, early and extensive metastasis, and is sensitive to chemotherapy and radiotherapy. The early treatment response rate of SCLC...
Main Authors: | Xuejun DOU, Zhiyuan WANG, Liang WANG, Weiqiang LU, Yunlei MA, Shaofa XU |
---|---|
Format: | Article |
Language: | zho |
Published: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2017-02-01
|
Series: | Chinese Journal of Lung Cancer |
Subjects: | |
Online Access: | http://dx.doi.org/10.3779/j.issn.1009-3419.2017.02.03 |
Similar Items
-
Effects of Multiple Factors on the Prognosis of pIIIa/N2 Patients with Non-small Cell Lung Cancer
by: Zhenrong ZHANG, et al.
Published: (2010-08-01) -
Surgical Therapeutic Strategy for Non-small Cell Lung Cancer with Mediastinal Lymph Node Metastasis (N2)
by: Yanchu TIAN, et al.
Published: (2010-04-01) -
Analysis of the Efficacy and Survival of Third-line Treatment
in Advanced Non-small Cell Lung Cancer
by: Lan SHAO, et al.
Published: (2012-06-01) -
Progress of Long Non-coding RNA in Non-small Cell Lung Cancer
by: Yachen ZHANG, et al.
Published: (2018-01-01) -
Advances in Surgical Treatment of Early Stage Non-small Cell Lung Cancer
by: Jian HU, et al.
Published: (2016-06-01)